Asian Phytoceuticals PCL (BKK:APCO)

Asian Phytoceuticals PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	196	210.83	292.76	250.38	223.35	247.73
Revenue Growth (YoY)	-13.53%	-27.99%	16.93%	12.10%	-9.84%	0.03%
Cost of Revenue	31.24	40.96	57.25	47.94	46.26	52.87
Gross Profit	164.77	169.87	235.52	202.44	177.09	194.85
Selling, General & Admin	118.25	120.1	119.72	116.49	106.29	124.73
Other Operating Expenses	-1.29	-3.34	-1.09	-2.08	-3.03	-5.41
Operating Expenses	116.96	116.76	118.63	114.41	103.27	119.32
Operating Income	47.81	53.11	116.89	88.03	73.82	75.53
Interest Expense	-1.63	-1.59	-0.66	-0.57	-0.86	-0.48
Interest & Investment Income	7.96	13.05	15.22	12.41	10.31	4.41
Earnings From Equity Investments	1.7	1.67	1.26	0.61	-0.28	-0.01
EBT Excluding Unusual Items	55.83	66.24	132.72	100.48	82.98	79.45
Gain (Loss) on Sale of Investments	8.16	1.73	0.47	-0.01	2.51	7.61
Pretax Income	63.98	67.98	133.18	100.47	85.49	87.07
Income Tax Expense	11.96	12.21	24.45	19.28	16.79	17.09
Earnings From Continuing Operations	52.02	55.77	108.74	81.2	68.7	69.98
Minority Interest in Earnings	-1.23	-1.06	-1.24	-0.28	-	-
Net Income	50.79	54.71	107.49	80.92	68.7	69.98
Net Income to Common	50.79	54.71	107.49	80.92	68.7	69.98
Net Income Growth	-20.12%	-49.10%	32.84%	17.78%	-1.82%	20.85%
Shares Outstanding (Basic)	559	601	601	600	600	600
Shares Outstanding (Diluted)	559	601	601	600	600	600
Shares Change (YoY)	-10.66%	0.12%	0.11%	-0.03%	-0.02%	0.01%
EPS (Basic)	0.09	0.09	0.18	0.13	0.11	0.12
EPS (Diluted)	0.09	0.09	0.18	0.13	0.11	0.12
EPS Growth	-10.59%	-49.16%	32.69%	17.82%	-1.80%	20.83%
Free Cash Flow	41.9	35.36	120.72	99.86	83.22	82.57
Free Cash Flow Per Share	0.07	0.06	0.20	0.17	0.14	0.14
Dividend Per Share	0.092	0.092	0.180	0.155	0.123	0.120
Dividend Growth	-48.89%	-48.89%	16.13%	25.61%	2.83%	26.32%
Gross Margin	84.06%	80.57%	80.45%	80.85%	79.29%	78.66%
Operating Margin	24.39%	25.19%	39.93%	35.16%	33.05%	30.49%
Profit Margin	25.91%	25.95%	36.72%	32.32%	30.76%	28.25%
Free Cash Flow Margin	21.38%	16.77%	41.24%	39.88%	37.26%	33.33%
EBITDA	53.18	59.29	123.69	94.84	81.48	87.51
EBITDA Margin	27.13%	28.12%	42.25%	37.88%	36.48%	35.32%
D&A For EBITDA	5.38	6.18	6.8	6.81	7.66	11.97
EBIT	47.81	53.11	116.89	88.03	73.82	75.53
EBIT Margin	24.39%	25.19%	39.93%	35.16%	33.05%	30.49%
Effective Tax Rate	18.69%	17.96%	18.36%	19.19%	19.64%	19.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.